Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine renal protection in elderly diabetic patients undergoing laparoscopic intestinal surgery
ChiCTR2000029224Phase 4Recruiting
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in diabetic glomerulosclerosis (2 arms), sponsored by China-Japan Union Hospital of Jilin University. Primary endpoints: Arterial blood gas analysis and Venous blood ion-kidney-glucose test. Started Jan 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2000029224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029224.